Allogene is pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer with the goal of making “off-the-shelf” CAR T cell therapies readily available on-demand, more reliably, and at greater scale to more patients.
Contact this Exhibitor
Products